RJA
VMD icon

Raymond James & Associates’s Viemed Healthcare VMD Stock Holding History

Raymond James & Associates’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-39,756
Closed -$239K – 4075
2022
Q3 		$239K Buy
+39,756
New +$255K ﹤0.01% 3329

Other funds holding VMD

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Voce Capital Management San Francisco, California $57.8M AUM 9.28% 1-Year Est. Return

Raymond James & Associates's VMD Position: Q4 2022 in Review

Raymond James & Associates sold out of Viemed Healthcare (VMD) in Q4 2022, closing a stake of 39,756 shares — an estimated $239K sold.

Raymond James & Associates first reported a position in VMD in Q3 2022 and held it in 1 quarter. The position peaked at $239K in Q3 2022. 81 funds tracked by Wall St. Rank hold VMD as of Q4 2022.

  • Raymond James & Associates reported no remaining Viemed Healthcare position as of Q4 2022 after selling out during the quarter.
  • Raymond James & Associates sold 39,756 Viemed Healthcare shares in Q4 2022, an estimated $239K.
  • Raymond James & Associates first reported a position in Viemed Healthcare in Q3 2022 and held it in 1 quarter.
  • Raymond James & Associates's Viemed Healthcare position peaked at $239K in Q3 2022.
  • 81 funds tracked by Wall St. Rank held Viemed Healthcare as of Q4 2022.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.